Confirmed clinical diagnosis of COVID-19 positive by Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) and/or SARS-CoV-2 Antigen Test performed 120 hours prior to patient inclusion in the study
LDH 250-400 U/L
Acceptance of informed consent signature
IMC: 18.5-30
Patients not participating in other trials
No hepatic and renal disorders
Possession of mental faculties to participate in the study
You may not be if
Patients with rare and specific viral diseases such as HIV
Patients undergoing chemotherapy during the last 2 months
Any other condition/pathology diagnosed by the medical specialist that prevents them from participating in the trial
Intake of vitamin complexes or functional foods
Clareo Health | Glycophosphopeptical AM3 A Potential Adjuvant in the Treatment of SARS-CoV-2
